Product Images Zanaflex
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Zanaflex NDC 73352-090 by Trifluent Pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - Zanaflex Label v1
This text provides information about Zanaflex® capsules containing 9.16 mg of tizanidine hydrochloride, equivalent to 8 mg of tizanidine base. It suggests referring to the package insert for prescribing information and storing the capsules at 20°C to 25°C. It emphasizes keeping the medication out of reach of children and dispenses in child-resistant containers. The text also mentions that Zanaflex® is a registered trademark of Legacy Pharma Inc. The capsules are not interchangeable with tizanidine or Zanaflex tablets. It indicates that the product is distributed by Trifluent Pharma, LLC in San Antonio, TX. Additionally, it provides the National Drug Code (NDC) for the capsules and relevant coding details.*
image description - zan01 0001 01a
image description - zan01 0001 02a
image description - zan01 0001 03a
This text describes the improvement in Ashworth Score over time for two doses of tizanidine (8 mg and 16 mg) as measured in hours post-dose.*
image description - zan01 0001 04a
This text appears to be describing the improvement in Ashworth Score with Tizanidine at a mean dose of 26.8 mg compared to a placebo. It mentions different study weeks and the titration and maintenance endpoint for the assessment.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
